Access and Safety-The FDA Drug Approval Conundrum

被引：0

作者：

Good, Chester B. ^{[1
]}

Peasah, Samuel K. ^{[2
]}

机构：

[1] Univ Pittsburgh, Insurance Serv Div, UPMC Hlth Plan, 600 Grant St,Univ Dr C, Pittsburgh, PA 15219 USA

[2] Univ Pittsburgh, Ctr Value Based Pharm Initiat, Insurance Serv Div, UPMC Hlth Plan, Pittsburgh, PA USA

来源：

关键词：

D O I：

10.1001/jamanetworkopen.2024.19823

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] FDA shortened drug approval time in 1995
不详
PUBLIC HEALTH REPORTS, 1996, 111 (04) : 290 - 290
[22] FDA drug approval summaries:: Pemetrexed (Alimta®)
Hazarika, M
White, RM
Johnson, JR
Pazdur, R
ONCOLOGIST, 2004, 9 (05): : 482 - 488
[23] 2004 Drug Approval Highlights FDA Update
Laustsen, Gary
Wimmett, Lynn
NURSE PRACTITIONER, 2005, 30 (02): : 14 - 16
[24] FDA drug approval summary:: Panitumumab (Vectibix™)
Giusti, Ruthann M.
Shastri, Kaushikkumar A.
Cohen, Martin H.
Keegan, Patricia
Pazdur, Richard
ONCOLOGIST, 2007, 12 (05): : 577 - 583
[25] RECENT FDA DRUG APPROVAL - TRANEXAMIC ACID
不详
CLINICAL PEDIATRICS, 1987, 26 (12) : 668 - 668
[26] FDA: Evidentiary Standards for Drug Development and Approval
Katz R.
NeuroRX, 2004, 1 (3): : 307 - 316
[27] FDA NEW DRUG APPROVAL POLICY - WHY
PATTERSON, R
GRAMMER, LC
NEW ENGLAND AND REGIONAL ALLERGY PROCEEDINGS, 1985, 6 (04): : 379 - 380
[28] The role of chemists in the FDA drug approval process
Furness, M. Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
[29] The FDA Accelerated Drug Approval Program Explained
不详
US PHARMACIST, 2023, 48 (10) : 56 - 57
[30] SB wins US FDA approval for drug
不详
EUROPEAN CHEMICAL NEWS, 1996, 65 (1720): : 23 - 23